About Tune Therapeutics
Tune Therapeutics is a private company based in Seattle, Washington, incorporated in 2020 in Delaware. It has reported $182,414,405 raised in one offering on Form D since January 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2023 | Jan 24, 2025 | $182,414,405of $208.0M target | 39 | $4.6M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Tune Therapeutics's Form D filed Jan 24, 2025.
DM
Dan McHugh
Executive officer and director
AM
Akira Matsuno
Executive officer
BS
Blythe Sather
Executive officer
DJ
Derek Jantz
Executive officer
CG
Charles Gersbach
Director
JM
John McHutchison
Director
YZ
Yuan Zhang
Executive officer
ZH
Zachary Hale
EVP, General Counsel and Secretary
AB
Ali Behbahani
Director